Pharmacological treatment with annexin A1 reduces atherosclerotic plaque burden in LDLR-/- mice on Western Type Diet

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Kusters, Dennis H M ^a   Chatrou, Martijn L ^a   Willems, Brecht A G ^a,b   De Saint Hubert, Marijke ^c   Bauwens, Matthias ^c   Van Der Vorst, Emiel ^a   Bena, Stefania ^d   Biessen, Erik A L ^a   Perretti, Mauro ^d   Schurgers, Leon J ^a   Reutelingsperger, Chris P M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FORMYLPEPTIDE RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; LIPOCORTIN 1; PHOSPHATIDYLSERINE; RECOMBINANT PROTEIN; TECHNETIUM 99M; TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRACHIOCEPHALIC TRUNK; C57BL 6 MOUSE; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PURIFICATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ADHERENCE INHIBITION; LOW DENSITY LIPOPROTEIN RECEPTOR KO MOUSE; MONOCYTE; MOUSE; MOUSE MODEL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SUBCLAVIAN ARTERY; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN DIET; ADVERSE EFFECTS; ANIMAL; BLOOD CELL; BONE MARROW CELL; DEFICIENCY; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG EFFECTS; GENETICS; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC;

MUS; PROKARYOTA; WHITE TIP DIE-BACK PHYTOPLASMA;

ANIMALS; ANNEXIN A1; BLOOD CELLS; BONE MARROW CELLS; DIET, WESTERN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG ADMINISTRATION ROUTES; HUMANS; IMMUNOPHENOTYPING; MACROPHAGES; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL; RECOMBINANT PROTEINS;

EID: 84939190711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130484     Document Type: Article

References (58)

1. Virmani R, Burke AP, Kolodgie FD, Farb A (2002) Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15: 439-446. PMID: 12476646
2. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126. PMID: 9887164
3. Kusters DH, Tegtmeier J, Schurgers LJ, Reutelingsperger CP (2012) Molecular imaging to identify the vulnerable plaque - from basic research to clinical practice. Mol Imaging Biol 14: 523-533. doi: 10.1007/s11307-012-0586-7 PMID: 22983911
4. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R (2013) Update on acute coronary syndromes: the pathologists' view. Eur Heart J 34: 719-728. doi: 10.1093/eurheartj/ehs411 PMID: 23242196
5. Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355. doi: 10.1016/j.cell.2011.04.005 PMID: 21529710
6. Mocsai A (2013) Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med 210: 1283-1299. doi: 10.1084/jem.20122220 PMID: 23825232
7. Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11: 519-531. doi: 10.1038/nri3024 PMID: 21785456
8. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122: 1837-1845. doi: 10.1161/CIRCULATIONAHA.110.961714 PMID: 20956207
9. de Jager SC, Bot I, Kraaijeveld AO, Korporaal SJ, Bot M, et al. (2013) Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. Arterioscler Thromb Vasc Biol 33: e75-83. doi: 10.1161/ATVBAHA.112.300857 PMID: 23288165
10. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, et al. (2008) Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 102: 209-217. PMID: 17991882
11. Gerke V, Creutz CE, Moss SE (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461. PMID: 15928709
12. Perretti M, D'Acquisto F (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9: 62-70. doi: 10.1038/nri2470 PMID: 19104500
13. Raynal P, Pollard HB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197: 63-93. PMID: 8155692
14. Bena S, Brancaleone V, Wang JM, Perretti M, Flower RJ (2012) Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J Biol Chem 287: 24690-24697. doi: 10.1074/jbc.M112.377101 PMID: 22610094
15. Rosengarth A, Luecke H (2003) A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J Mol Biol 326: 1317-1325. PMID: 12595246
16. Perretti M (2003) The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol Sci 24: 574-579. PMID: 14607080
17. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, et al. (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281: 19588-19599. PMID: 16675446
18. Vong L, D'Acquisto F, Pederzoli-Ribeil M, Lavagno L, Flower RJ, et al. (2007) Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J Biol Chem 282: 29998-30004. PMID: 17681950
19. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, et al. (2006) Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107: 2123-2130. PMID: 16278303
20. Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ (1993) Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol 151: 4306-4314. PMID: 8409403
21. D'Amico M, Di Filippo C, La M, Solito E, McLean PG, et al. (2000) Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J 14: 1867-1869. PMID: 11023969
22. Dalli J, Consalvo AP, Ray V, Di Filippo C, D'Amico M, et al. (2013) Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J Immunol 190: 6478-6487. doi: 10.4049/jimmunol.1203000 PMID: 23686496
23. Perretti M, Getting SJ, Solito E, Murphy PM, Gao JL (2001) Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol 158: 1969-1973. PMID: 11395373
24. Drechsler M, de Jong R, Rossaint J, Viola JR, Leoni G, et al. (2015) Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment. Circ Res 116: 827-835. doi: 10.1161/CIRCRESAHA.116.305825 PMID: 25520364
25. Schutters K, Kusters DH, Chatrou ML, Montero-Melendez T, Donners M, et al. (2013) Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells. Cell Death Differ 20: 49-56. doi: 10.1038/cdd.2012.107 PMID: 22955945
26. Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC, et al. (1992) Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 267: 17907-17912. PMID: 1387643
27. Davies JQ, Gordon S (2005) Isolation and culture of murine macrophages. Methods Mol Biol 290: 91-103. PMID: 15361657
28. Burgmaier M, Schutters K, Willems B, van der Vorst EP, Kusters D, et al. (2014) AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(-/-) mice. J Cell Mol Med 18: 2117-2124. doi: 10.1111/jcmm.12374 PMID: 25214012
29. Pederzoli-Ribeil M, Maione F, Cooper D, Al-Kashi A, Dalli J, et al. (2010) Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood 116: 4288-4296. doi: 10.1182/blood-2010-02-270520 PMID: 20705760
30. van Genderen H, Kenis H, Lux P, Ungeth L, Maassen C, et al. (2006) In vitro measurement of cell death with the annexin A5 affinity assay. Nat Protoc 1: 363-367. PMID: 17406257
31. De Saint-Hubert M, Mottaghy FM, Vunckx K, Nuyts J, Fonge H, et al. (2010) Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo. Bioorg Med Chem 18: 1356-1363. doi: 10.1016/j.bmc.2009.12.021 PMID: 20053567
32. De Saint-Hubert M, Bauwens M, Deckers N, Drummen M, Douma K, et al. (2013) In Vivo Molecular Imaging of Apoptosisand Necrosis in Atherosclerotic PlaquesUsing MicroSPECT-CT and MicroPET-CT Imaging. Mol Imaging Biol.
33. Tchaikovski SN, Vanv BJ, Rosing J, Tans G (2007) Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. J Thromb Haemost 5: 2079-2086. PMID: 17666016
34. Kenis H, van Genderen H, Bennaghmouch A, Rinia HA, Frederik P, et al. (2004) Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J Biol Chem 279: 52623-52629. PMID: 15381697
35. Ungethum L, Kenis H, Nicolaes GA, Autin L, Stoilova-McPhie S, et al. (2011) Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies. J Biol Chem 286: 1903-1910. doi: 10.1074/jbc.M110.163527 PMID: 21078669
36. Locatelli I, Sutti S, Jindal A, Vacchiano M, Bozzola C, et al. (2014) Endogenous annexin A1 IS a novel protective determinant in nonalcoholic steatohepatitis (NASH). Hepatology.
37. Girol AP, Mimura KK, Drewes CC, Bolonheis SM, Solito E, et al. (2013) Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro. J Immunol 190: 5689-5701. doi: 10.4049/jimmunol.1202030 PMID: 23645879
38. Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, et al. (2013) Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest 123: 443-454. doi: 10.1172/JCI65831 PMID: 23241962
39. Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, et al. (2015) Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med 7: 275ra220.
40. Vangestel C, Peeters M, Oltenfreiter R, D'Asseler Y, Staelens S, et al. (2010) In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells. Nucl Med Biol 37: 965-975. doi: 10.1016/j.nucmedbio.2010.06.007 PMID: 21055628
41. Soehnlein O (2012) Multiple roles for neutrophils in atherosclerosis. Circ Res 110: 875-888. doi: 10.1161/CIRCRESAHA.111.257535 PMID: 22427325
42. Bot I, Daissormont IT, Zernecke A, van Puijvelde GH, Kramp B, et al. (2014) CXCR4 blockade induces atherosclerosis by affecting neutrophil function. J Mol Cell Cardiol 74: 44-52. doi: 10.1016/j.yjmcc.2014.04.021 PMID: 24816217
43. Doring Y, Drechsler M, Soehnlein O, Weber C (2015) Neutrophils in atherosclerosis: from mice to man. Arterioscler Thromb Vasc Biol 35: 288-295. doi: 10.1161/ATVBAHA.114.303564 PMID: 25147339
44. Hartwig H, Silvestre Roig C, Daemen M, Lutgens E, Soehnlein O (2015) Neutrophils in atherosclerosis. A brief overview. Hamostaseologie 35: 121-127. doi: 10.5482/HAMO-14-09-0040 PMID: 25385255
45. Drechsler M, de Jong RJ, Rossaint J, Viola J, Leoni G, et al. (2014) Annexin A1 Counteracts Chemokine-Induced Arterial Myeloid Cell Recruitment. Circ Res.
46. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, et al. (2005) ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 106: 584-592. PMID: 15811956
47. Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, et al. (2012) Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 92: 249-258. doi: 10.1189/jlb.0112008 PMID: 22493082
48. Lim LH, Solito E, Russo-Marie F, Flower RJ, Perretti M (1998) Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A 95: 14535-14539. PMID: 9826735
49. Nakagawa M, Terashima T, D'Yachkova Y, Bondy GP, Hogg JC, et al. (1998) Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation 98: 2307-2313. PMID: 9826319
50. Locatelli I, Sutti S, Jindal A, Vacchiano M, Bozzola C, et al. (2014) Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. Hepatology 60: 531-544. doi: 10.1002/hep.27141 PMID: 24668763
51. Libby P, Lichtman AH, Hansson GK (2013) Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38: 1092-1104. doi: 10.1016/j.immuni.2013.06.009 PMID: 23809160
52. Stoger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, et al. (2012) Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225: 461-468. doi: 10.1016/j.atherosclerosis.2012.09.013 PMID: 23078881
53. Cardilo-Reis L, Gruber S, Schreier SM, Drechsler M, Papac-Milicevic N, et al. (2012) Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol Med 4: 1072-1086. doi: 10.1002/emmm.201201374 PMID: 23027612
54. Tabas I (2005) Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 25: 2255-2264. PMID: 16141399
55. Tabas I, Tall A, Accili D (2010) The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res 106: 58-67. doi: 10.1161/CIRCRESAHA.109.208488 PMID: 20056946
56. Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, et al. (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178: 4595-4605. PMID: 17372018
57. Blume KE, Soeroes S, Keppeler H, Stevanovic S, Kretschmer D, et al. (2012) Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic "find-me" signal. J Immunol 188: 135-145. doi: 10.4049/jimmunol.1004073 PMID: 22116825
58. Yang YH, Aeberli D, Dacumos A, Xue JR, Morand EF (2009) Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper. J Immunol 183: 1435-1445. doi: 10.4049/jimmunol.0804000 PMID: 19553536